Logo image of GEL

GENESIS ENERGY L.P. (GEL) Stock Fundamental Analysis

NYSE:GEL - New York Stock Exchange, Inc. - US3719271047 - Currency: USD

14.16  +0.4 (+2.91%)

Fundamental Rating

2

Overall GEL gets a fundamental rating of 2 out of 10. We evaluated GEL against 212 industry peers in the Oil, Gas & Consumable Fuels industry. GEL may be in some trouble as it scores bad on both profitability and health. GEL is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

GEL had negative earnings in the past year.
In the past year GEL had a positive cash flow from operations.
GEL had negative earnings in 4 of the past 5 years.
Each year in the past 5 years GEL had a positive operating cash flow.
GEL Yearly Net Income VS EBIT VS OCF VS FCFGEL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

GEL's Return On Assets of -2.15% is on the low side compared to the rest of the industry. GEL is outperformed by 75.00% of its industry peers.
GEL's Return On Equity of -52.36% is on the low side compared to the rest of the industry. GEL is outperformed by 86.32% of its industry peers.
With a Return On Invested Capital value of 3.28%, GEL is not doing good in the industry: 67.45% of the companies in the same industry are doing better.
GEL had an Average Return On Invested Capital over the past 3 years of 3.84%. This is significantly below the industry average of 27.42%.
Industry RankSector Rank
ROA -2.15%
ROE -52.36%
ROIC 3.28%
ROA(3y)-0.61%
ROA(5y)-2.84%
ROE(3y)-16.02%
ROE(5y)-29.14%
ROIC(3y)3.84%
ROIC(5y)2.72%
GEL Yearly ROA, ROE, ROICGEL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

Looking at the Operating Margin, with a value of 8.64%, GEL is doing worse than 65.09% of the companies in the same industry.
GEL's Operating Margin has declined in the last couple of years.
The Gross Margin of GEL (21.20%) is worse than 66.51% of its industry peers.
GEL's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.64%
PM (TTM) N/A
GM 21.2%
OM growth 3Y29.46%
OM growth 5Y-4.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.28%
GM growth 5Y-3.83%
GEL Yearly Profit, Operating, Gross MarginsGEL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GEL is destroying value.
Compared to 1 year ago, GEL has about the same amount of shares outstanding.
GEL has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, GEL has a worse debt to assets ratio.
GEL Yearly Shares OutstandingGEL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
GEL Yearly Total Debt VS Total AssetsGEL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

GEL has a Debt/Equity ratio of 17.00. This is a high value indicating a heavy dependency on external financing.
GEL has a Debt to Equity ratio of 17.00. This is amonst the worse of the industry: GEL underperforms 92.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 17
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.4
WACC8.15%
GEL Yearly LT Debt VS Equity VS FCFGEL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

GEL has a Current Ratio of 1.06. This is a normal value and indicates that GEL is financially healthy and should not expect problems in meeting its short term obligations.
GEL has a Current ratio (1.06) which is comparable to the rest of the industry.
GEL has a Quick Ratio of 1.06. This is a bad value and indicates that GEL is not financially healthy enough and could expect problems in meeting its short term obligations.
GEL has a Quick ratio (0.93) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.93
GEL Yearly Current Assets VS Current LiabilitesGEL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2

3. Growth

3.1 Past

The earnings per share for GEL have decreased strongly by -504.55% in the last year.
GEL shows a decrease in Revenue. In the last year, the revenue decreased by -6.64%.
Measured over the past years, GEL shows a small growth in Revenue. The Revenue has been growing by 3.64% on average per year.
EPS 1Y (TTM)-504.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-187.5%
Revenue 1Y (TTM)-6.64%
Revenue growth 3Y11.75%
Revenue growth 5Y3.64%
Sales Q2Q%-6.27%

3.2 Future

Based on estimates for the next years, GEL will show a very strong growth in Earnings Per Share. The EPS will grow by 42.92% on average per year.
The Revenue is expected to decrease by -11.54% on average over the next years. This is quite bad
EPS Next Y93.19%
EPS Next 2Y69.19%
EPS Next 3Y42.92%
EPS Next 5YN/A
Revenue Next Year-22.62%
Revenue Next 2Y-11.54%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
GEL Yearly Revenue VS EstimatesGEL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B
GEL Yearly EPS VS EstimatesGEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 -2 -3

1

4. Valuation

4.1 Price/Earnings Ratio

GEL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GEL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GEL Price Earnings VS Forward Price EarningsGEL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GEL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.64
GEL Per share dataGEL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

GEL's earnings are expected to grow with 42.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y69.19%
EPS Next 3Y42.92%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.66%, GEL is a good candidate for dividend investing.
GEL's Dividend Yield is comparable with the industry average which is at 7.52.
Compared to an average S&P500 Dividend Yield of 2.52, GEL pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.66%

5.2 History

The dividend of GEL decreases each year by -12.24%.
GEL has paid a dividend for at least 10 years, which is a reliable track record.
GEL has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-12.24%
Div Incr Years1
Div Non Decr Years3
GEL Yearly Dividends per shareGEL Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

The earnings of GEL are negative and hence is the payout ratio. GEL will probably not be able to sustain this dividend level.
DP-107.5%
EPS Next 2Y69.19%
EPS Next 3Y42.92%
GEL Yearly Income VS Free CF VS DividendGEL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

GENESIS ENERGY L.P.

NYSE:GEL (4/17/2025, 8:24:25 PM)

14.16

+0.4 (+2.91%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-13 2025-02-13/bmo
Earnings (Next)05-08 2025-05-08/bmo
Inst Owners73.41%
Inst Owner Change-0.07%
Ins Owners11.58%
Ins Owner Change0.05%
Market Cap1.73B
Analysts80
Price Target16.32 (15.25%)
Short Float %3.3%
Short Ratio4.84
Dividend
Industry RankSector Rank
Dividend Yield 4.66%
Yearly Dividend1.33
Dividend Growth(5Y)-12.24%
DP-107.5%
Div Incr Years1
Div Non Decr Years3
Ex-Date04-30 2025-04-30 (0.165)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-95.15%
Min EPS beat(2)-216.83%
Max EPS beat(2)26.54%
EPS beat(4)1
Avg EPS beat(4)-476.62%
Min EPS beat(4)-991.09%
Max EPS beat(4)26.54%
EPS beat(8)2
Avg EPS beat(8)-288.16%
EPS beat(12)4
Avg EPS beat(12)-226.95%
EPS beat(16)4
Avg EPS beat(16)-825.42%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)17.07%
PT rev (3m)17.07%
EPS NQ rev (1m)-4.55%
EPS NQ rev (3m)4.17%
EPS NY rev (1m)73.91%
EPS NY rev (3m)76.92%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-18.79%
Revenue NY rev (3m)-23.36%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.58
P/FCF N/A
P/OCF 4.42
P/B 5.99
P/tB N/A
EV/EBITDA 11.64
EPS(TTM)-0.89
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-1.59
FCFYN/A
OCF(TTM)3.2
OCFY22.6%
SpS24.22
BVpS2.36
TBVpS-0.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.15%
ROE -52.36%
ROCE 4.15%
ROIC 3.28%
ROICexc 3.29%
ROICexgc 3.52%
OM 8.64%
PM (TTM) N/A
GM 21.2%
FCFM N/A
ROA(3y)-0.61%
ROA(5y)-2.84%
ROE(3y)-16.02%
ROE(5y)-29.14%
ROIC(3y)3.84%
ROIC(5y)2.72%
ROICexc(3y)3.85%
ROICexc(5y)2.73%
ROICexgc(3y)4.15%
ROICexgc(5y)2.94%
ROCE(3y)4.86%
ROCE(5y)3.44%
ROICexcg growth 3Y37.71%
ROICexcg growth 5Y-1.21%
ROICexc growth 3Y38.44%
ROICexc growth 5Y-1.07%
OM growth 3Y29.46%
OM growth 5Y-4.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.28%
GM growth 5Y-3.83%
F-Score3
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 17
Debt/FCF N/A
Debt/EBITDA 8.64
Cap/Depr 187.49%
Cap/Sales 19.79%
Interest Coverage 0.8
Cash Conversion 68.84%
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.93
Altman-Z N/A
F-Score3
WACC8.15%
ROIC/WACC0.4
Cap/Depr(3y)184%
Cap/Depr(5y)139.62%
Cap/Sales(3y)18.17%
Cap/Sales(5y)15.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-504.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-187.5%
EPS Next Y93.19%
EPS Next 2Y69.19%
EPS Next 3Y42.92%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.64%
Revenue growth 3Y11.75%
Revenue growth 5Y3.64%
Sales Q2Q%-6.27%
Revenue Next Year-22.62%
Revenue Next 2Y-11.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-22.27%
EBIT growth 3Y44.67%
EBIT growth 5Y-1.08%
EBIT Next Year138.59%
EBIT Next 3Y39.78%
EBIT Next 5YN/A
FCF growth 1Y-97.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.79%
OCF growth 3Y5.06%
OCF growth 5Y0.5%